Literature DB >> 11352421

Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.

J K Wildemore1, L Schuchter, R Mick, M Synnestvedt, R Elenitsas, I Bedrosian, B J Czerniecki, D Guerry, S R Lessin, D E Elder, L P Bucky.   

Abstract

Despite improvements in the identification and treatment of melanoma, local recurrence continues to challenge the success of current melanoma therapy. A retrospective analysis of 1,996 patients presenting from 1990 to 1997 at the Pigmented Lesion Group of the University of Pennsylvania was performed to assess clinical characteristics and outcomes of locally recurrent melanoma. The cases were analyzed by chart and pathological slide review. A control group was identified for statistical comparison. The incidence of locally recurrent melanoma during the study period was 2.2%. Lentigo maligna melanoma (LMM) accounted for 37% of the local recurrences. Increased tumor thickness and microsatellites were associated with "early" local recurrence and decreased survival from time of recurrence. Nineteen percent of the local recurrences occurred more than 5 years after the initial definitive treatment. The preponderance of locally recurrent LMM suggests the need for refinements in the techniques of margin identification and surgical excision of LMM. Tumors with increased thickness and microsatellites should receive particularly close attention. Lastly, with nearly 20% of the local recurrences occurring more than 5 years after the initial date of treatment, the authors suggest extending the follow-up time for all melanoma lesions beyond 5 years.

Entities:  

Mesh:

Year:  2001        PMID: 11352421     DOI: 10.1097/00000637-200105000-00006

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  4 in total

1.  Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.

Authors:  J Gregory McKinnon; Emma C Starritt; Richard A Scolyer; William H McCarthy; John F Thompson
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

2.  Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?

Authors:  Katharine A Yao; Eddy C Hsueh; Richard Essner; Leland J Foshag; Leslie A Wanek; Donald L Morton
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

3.  Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.

Authors:  Jeffrey P North; Toshiro Kageshita; Daniel Pinkel; Philip E LeBoit; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2008-03-06       Impact factor: 8.551

4.  Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.

Authors:  Yuka Okada; Naoki Okada; Shinsaku Nakagawa; Hiroyuki Mizuguchi; Koichi Takahashi; Nobuyasu Mizuno; Takuya Fujita; Akira Yamamoto; Takao Hayakawa; Tadanori Mayumi
Journal:  Jpn J Cancer Res       Date:  2002-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.